IMM 1.49% 34.0¢ immutep limited

more credibility

  1. 664 Posts.
    http://www.themarketfinancial.com/biovest-international-otcbvtithe-next-potential-winner-in-cancer-immunotherapy-vaccine-after-dendreon-nasdaqdndn/108696

    They keep coming.
    When NASDAQ listing comes the ground may be quite fertile.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.